Scoping review identifies barriers and facilitators for AI adoption in diabetes management among healthcare workers, suggesting a bottom-up approach for effective integration.
Key Points
The adoption of artificial intelligence tools in diabetes management faces multiple barriers, including high costs and data security issues.
Perceived facilitators for AI use include enhanced clinical efficiency and organizational support, promoting wider acceptance in healthcare settings.
A scoping review methodology was utilized to analyze quantitative and qualitative data regarding AI implementation challenges.
Engaging healthcare workers in the development of AI solutions can aid in addressing barriers and aligning innovations with public health priorities.